Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
4.260
-0.230 (-5.12%)
At close: Dec 20, 2024, 4:00 PM
4.310
+0.050 (1.17%)
After-hours: Dec 20, 2024, 7:43 PM EST
Cardiff Oncology Employees
As of December 31, 2023, Cardiff Oncology had 32 total employees, including 31 full-time and 1 part-time employees. The number of employees increased by 6 or 23.08% compared to the previous year.
Employees
32
Change (1Y)
6
Growth (1Y)
23.08%
Revenue / Employee
$21,500
Profits / Employee
-$1,343,906
Market Cap
217.83M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
Aurora Cannabis | 1,073 |
BGM Group | 298 |
Pulmonx | 279 |
Electromed | 174 |
Nautilus Biotechnology | 167 |
Heron Therapeutics | 126 |
Alpha Tau Medical | 121 |
CRDF News
- 7 days ago - Undercovered Dozen: Ubiquiti, Ready Capital, Cardiff Oncology, Vodafone + - Seeking Alpha
- 9 days ago - Cardiff Oncology: The Long-Awaited First-Line MCRC Data Are Here, But The Work Is Just Beginning - Seeking Alpha
- 11 days ago - Cardiff Oncology: Beats Standard Of Care In First Line Metastatic Colorectal Cancer - Seeking Alpha
- 11 days ago - Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering - GlobeNewsWire
- 11 days ago - Cardiff Oncology Announces Positive Initial Data from First-line RAS-mutated mCRC Clinical Trial - GlobeNewsWire
- 7 weeks ago - Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC - GlobeNewsWire
- 2 months ago - Cardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC Market - Seeking Alpha
- 4 months ago - Cardiff: Second Half Of 2024 mCRC Data Is Major Inflection Point - Seeking Alpha